These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 19883086)

  • 21. Design and multi-step synthesis of chalcone-polyamine conjugates as potent antiproliferative agents.
    Rioux B; Pouget C; Fidanzi-Dugas C; Gamond A; Laurent A; Semaan J; Pinon A; Champavier Y; Léger DY; Liagre B; Duroux JL; Fagnère C; Sol V
    Bioorg Med Chem Lett; 2017 Sep; 27(18):4354-4357. PubMed ID: 28838697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promising anti-inflammatory effects of chalcones via inhibition of cyclooxygenase, prostaglandin E
    Ur Rashid H; Xu Y; Ahmad N; Muhammad Y; Wang L
    Bioorg Chem; 2019 Jun; 87():335-365. PubMed ID: 30921740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of nuclear factor-kappaB and heme oxygenase-1 in the mechanism of action of an anti-inflammatory chalcone derivative in RAW 264.7 cells.
    Alcaraz MJ; Vicente AM; Araico A; Dominguez JN; Terencio MC; Ferrándiz ML
    Br J Pharmacol; 2004 Aug; 142(7):1191-9. PubMed ID: 15249426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products.
    Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB
    Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of a new dihydroeugenol-chalcone hybrid with cytotoxic and anti-migratory potential: A dual-action hit for cancer therapeutics.
    Nakao IA; Almeida TC; Cardoso Reis AC; Coutinho GG; Hermenegildo AM; Cordeiro CF; da Silva GN; Dias DF; Brandão GC; Pinto Braga SF; de Souza TB
    Bioorg Med Chem; 2023 Dec; 96():117516. PubMed ID: 37944413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2'-hydroxychalcone inhibits nuclear factor-kappaB and blocks tumor necrosis factor-alpha- and lipopolysaccharide-induced adhesion of neutrophils to human umbilical vein endothelial cells.
    Madan B; Batra S; Ghosh B
    Mol Pharmacol; 2000 Sep; 58(3):526-34. PubMed ID: 10953045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isoliquiritigenin isolated from the roots of Glycyrrhiza uralensis inhibits LPS-induced iNOS and COX-2 expression via the attenuation of NF-kappaB in RAW 264.7 macrophages.
    Kim JY; Park SJ; Yun KJ; Cho YW; Park HJ; Lee KT
    Eur J Pharmacol; 2008 Apr; 584(1):175-84. PubMed ID: 18295200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and anti-cancer activity evaluation of novel prenylated and geranylated chalcone natural products and their analogs.
    Wang HM; Zhang L; Liu J; Yang ZL; Zhao HY; Yang Y; Shen D; Lu K; Fan ZC; Yao QW; Zhang YM; Teng YO; Peng Y
    Eur J Med Chem; 2015 Mar; 92():439-48. PubMed ID: 25590864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and cytotoxicity of 2,5-dihydroxychalcones and related compounds.
    Nam NH; Hong DH; You YJ; Kim Y; Bang SC; Kim HM; Ahn BZ
    Arch Pharm Res; 2004 Jun; 27(6):581-8. PubMed ID: 15283456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between the structures of flavonoids and their NF-κB-dependent transcriptional activities.
    Shin SY; Woo Y; Hyun J; Yong Y; Koh D; Lee YH; Lim Y
    Bioorg Med Chem Lett; 2011 Oct; 21(20):6036-41. PubMed ID: 21907578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, Anticancer Activity, and Docking Studies of Novel Hydroquinone-Chalcone-Pyrazoline Hybrid Derivatives.
    Maldonado J; Oliva A; Guzmán L; Molinari A; Acevedo W
    Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and anti-proliferative activity of fluoro-substituted chalcones.
    Burmaoglu S; Algul O; Anıl DA; Gobek A; Duran GG; Ersan RH; Duran N
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3172-3176. PubMed ID: 27217001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chalcone Scaffolds as Anticancer Drugs: A Review on Molecular Insight in Action of Mechanisms and Anticancer Properties.
    Shukla S; Sood AK; Goyal K; Singh A; Sharma V; Guliya N; Gulati S; Kumar S
    Anticancer Agents Med Chem; 2021; 21(13):1650-1670. PubMed ID: 33238850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chalcone hybrids as potential anticancer agents: Current development, mechanism of action, and structure-activity relationship.
    Gao F; Huang G; Xiao J
    Med Res Rev; 2020 Sep; 40(5):2049-2084. PubMed ID: 32525247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of 3',4',5'-trimethoxychalcone analogues as inhibitors of nitric oxide production and tumor cell proliferation.
    Rao YK; Fang SH; Tzeng YM
    Bioorg Med Chem; 2009 Dec; 17(23):7909-14. PubMed ID: 19875299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of lipopolysaccharide-induced expression of inducible nitric oxide synthase and tumor necrosis factor-alpha by 2'-hydroxychalcone derivatives in RAW 264.7 cells.
    Ban HS; Suzuki K; Lim SS; Jung SH; Lee S; Ji J; Lee HS; Lee YS; Shin KH; Ohuchi K
    Biochem Pharmacol; 2004 Apr; 67(8):1549-57. PubMed ID: 15041472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure optimization of an F-indole-chalcone (FC116) on 4-methoxyphenyl group and therapeutic potential against colorectal cancers with low cytotoxicity.
    Du B; Liu X; Luan X; Zhang W; Zhuang C
    Bioorg Chem; 2023 Jun; 135():106531. PubMed ID: 37043882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-cancer chalcones: Structural and molecular target perspectives.
    Mahapatra DK; Bharti SK; Asati V
    Eur J Med Chem; 2015 Jun; 98():69-114. PubMed ID: 26005917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, and biological evaluation of potent 1,2,3,4-tetrahydroisoquinoline derivatives as anticancer agents targeting NF-κB signaling pathway.
    Sim S; Lee S; Ko S; Phuong Bui B; Linh Nguyen P; Cho J; Lee K; Kang JS; Jung JK; Lee H
    Bioorg Med Chem; 2021 Sep; 46():116371. PubMed ID: 34500188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Cytoprotective Effects of E-α-(4-Methoxyphenyl)-2',3,4,4'-Tetramethoxychalcone (E-α-p-OMe-C6H4-TMC)--A Novel and Non-Cytotoxic HO-1 Inducer.
    Kaufmann KB; Al-Rifai N; Ulbrich F; Schallner N; Rücker H; Enzinger M; Petkes H; Pitzl S; Goebel U; Amslinger S
    PLoS One; 2015; 10(11):e0142932. PubMed ID: 26565402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.